| ||
| Orexigen, Sunesis lead drug stocks lower MarketWatch Shares of Exelixis /quotes/zigman/82395/quotes/nls/exel EXEL -20.20% plunged 20% after the company revealed that six patients, or about 1% of those enrolled, in a clinical trial for its cancer agent cabozantinib had died of drug-related complications. ... See all stories on this topic » | ||
| Investing in Healthcare: Novartis, Oxigene, Bayer and More Wall St. Cheat Sheet The firm also has reported encouraging data on its non-small cell lung cancer drug, Zybrestat. Impax Laboratories (NASDAQ:IPXL) shares are down 4.83% today upon news of an FDA warning about "deviations from current Good Manufacturing Practice for ... See all stories on this topic » | ||
| Society needs greater debate on euthanasia Courier Mail At one end, they extend life with medication; at the other extreme, many engage in "passive" euthanasia when they increase doses of powerful drugs to pained, terminally ill patients to the point that heart and lung function ceases. ... See all stories on this topic » | ||
| Embargoed news from Annals of Internal Medicine EurekAlert (press release) "This study showed that—as has been previously shown for heart attacks and for lung cancer—that smoking is actually very harmful for the development PAD," said Eruna Pradhan, Assistant Professor of Medicine at Harvard Medical School and an author of ... See all stories on this topic » |
| ||
| Studying Cancer Cells Helps Doctors Predict Drug Reactions By The Huffington Post News Editors In a separate study, a consortium of lung cancer experts studied tumor samples from 830 patients and found that about half of them had at least one of 10 genetic mutations known to drive lung cancer and could be used to guide doctors' ... The Full Feed from HuffingtonPost.com - http://www.huffingtonpost.com/raw_feed_index.rdf | ||
| Bristol-Myers pitches its cancer medicine pipeline He said Bristol-Myers is aiming to become a leader in immune-based cancer treatments. It has been testing Yervoy against prostate cancer and lung cancer in combination with other treatments, and has five other, ... KLAS - National News - http://www.8newsnow.com/category/13530/national-news?redirected=true | ||
| Pharmalot… Pharmalittle… Good Morning // Pharmalot By Ed Silverman To extend the above argument, a recent study of cancer registries from Washington state, as reported on showed that families of lung cancer patients on chemotherapy are 27 times more likely to file for personal bankruptcy than the ... Pharmalot - http://www.pharmalot.com/ |
| ||
| Taxol, Carboplatin, Hycodan, Codeine, Decadron drug interaction ... The patient has Febrile Neutropenia · Taxol, Paraplatin, Decadron, Benadryl, Anzemet drug interactions for Lung Cancer Stage Unspecified (excl Metastatic ... www.ehealthme.com/sa/2140148/gastroenteritis+viral | ||
| Hospitals hunt substitutes as drug shortages rise - Health ... Study: Pfizer lung cancer pill may double survival. A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over ... www.fresnobee.com/2011/.../hospitals-hunt-substitutes-as.html | ||
| Information obtained from ClinicalTrials.gov on June 02, 2011 Link ... Completed October 1999 Phase 1 Interventional Primary Purpose: Treatment Esophageal Cancer Lung Cancer Malignant Mesothelioma Metastatic Cancer Drug ... clinicaltrials.gov/show/NCT00019825?displayxml=true | ||
| What Are The Endometrial Cancer Medications? - Cancer - Zimbio advanced ovarian cancer , cancer endometrial recurrence , cancer lung , cancer survivors ... What Are The Endometrial Cancer Medications? Report Email ... www.zimbio.com/Cancer/..._/Endometrial+Cancer+Medication... | ||
| Roche's Tarceva helps lung cancer patients ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease ... www.qualityhealth.com/.../roches-tarceva-helps-lung-cancer-p... | ||
| Thyroid Medication With No Insurance | Public Option Please Ovarian, Breast, Lung Cancer Medication and Health Insurance – What You Should Know. Like many cancer drugs on the market, Taxol and health insurance do not ... publicoptionplease.com/.../thyroid-medication-with-no-insura... | ||
| News - Abbott Completes Submission of New Molecular Test Intended ... "The Abbott ALK FISH test is designed to help physicians select appropriate patients with non-small-cell lung cancer for targeted drug treatment. ... www.pharma-mag.com/.../Abbott-Completes-Submission-of-N... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment